Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 200   

Articles published

PFE 30.25 +0.16 (0.53%)
price chart
Pfizer Made $101 Billion Bid for AstraZeneca: Sunday Times of London
Pfizer Inc. (PFE) approached AstraZeneca Plc (AZN) about acquiring the U.K. drugmaker in a deal that would value the company at more than 60 billion pounds ($101 billion), according to a media report.
Pfizer Approached AstraZeneca in $101 Billion Bid, Times Says  San Diego Source (subscription)
Pfizer considers $100 bn bid for AstraZeneca: report  Livemint
Related articles »  
Report: Pfizer tentatively offers to acquire AstraZeneca for �60B+
Pfizer is looking to do something with a $70B cash pile that it has accumulated overseas; repatriating the money to the U.S.
Pfizer Inc. (NYSE:PFE): Breakthroughs in Vaccines and Oncology
Tomahawk, WI 03/27/2014 (Basicsmedia) - While Pfizer Inc. (NYSE:PFE) got some bad news when its Celebrex patent was invalidated by a U.S.
Pfizer Inc. (NYSE:PFE): Potential New Oncology Therapy
Pfizer Inc. (NYSE:PFE) announced in early February some positive results from a randomized Phase 2 trial of palbociclib in combination with letrozole (for blocking the synthesis of estrogen) in post-menopausal women with estrogen receptor (ER) positive ...
Large Cap Active Runners: Facebook Inc (NASDAQ:FB), Pfizer Inc. (NYSE:
Facebook Inc (NASDAQ:FB) users in the U.S. will soon be able to see which of their friends are in close proximity using a new feature the company is launching on Thursday. Facebook Inc (NASDAQ:FB) shares after opening at $59.30 moved to $60.58 on last ...
Related articles »  
Why Questcor Is Soaring Today While Pfizer Is Down
Pfizer Inc. (PFE) announced yesterday that its phase 2 randomized study, PALOMA-1, of palbociclib combined with letrozole, achieved its primary endpoint.
How Pfizer Inc. (NYSE:PFE) and Questcor Pharmaceuticals (NASDAQ:QCOR ...  iStreetWire
Buzz Stocks: Yahoo! Inc., Potash Corp./Saskatchewan (USA), Questcor ...  Schaeffers Research (blog)
Related articles »  
Company Update: Pfizer Inc (NYSE:PFE) � Teva settles patent suit with Pfizer ...
Pfizer Inc (NYSE:PFE) [Reuters] - Teva Pharmaceutical Industries Ltd signed a deal that allows the Israeli drugmaker to launch a generic version of Pfizer Inc's blockbuster painkiller Celebrex in December. A U.S. court in March invalidated a patent ...
Pfizer Vs. Eli Lilly, Novartis In Breast Cancer Race
If the company must complete a Phase 3 study, which is already underway, approval might be delayed a couple of years, according to the ISI Group.
Teva, Pfizer settle patent lawsuit over blockbuster painkiller
(Reuters) - Teva Pharmaceutical Industries Ltd said it settled a patent lawsuit with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster painkiller Celebrex in December.
Teva Settles Patent Litigation with Pfizer on Celebrex(R)  Wall Street Journal
Related articles »  
Vigo County Parks aquire 824 acres from Pfizer Inc.
The Board closed on 824 acres formerly owned by Pfizer Inc on Tuesday. The land is in southern Vigo County, mostly north of Dallas Road.